Our results demonstrate that PTX3 is produced in the CNS of GALC-deficient Krabbe patients and twitcher mice and point to a possible protective role of this immune modulator by reducing, at least in part, the neuroinflammatory response that characterizes GLD. Here, PTX3 is linked to Krabbe disease.